Literature DB >> 15029877

New intragenic deletions in the Phex gene clarify X-linked hypophosphatemia-related abnormalities in mice.

Bettina Lorenz-Depiereux1, Victoria E Guido, Kenneth R Johnson, Qing Yin Zheng, Leona H Gagnon, Joiel D Bauschatz, Muriel T Davisson, Linda L Washburn, Leah Rae Donahue, Tim M Strom, Eva M Eicher.   

Abstract

X-linked hypophosphatemic rickets (XLH) in humans is caused by mutation in the PHEX gene. Previously, three mutations in the mouse Phex gene have been reported: Phex(Hyp), Gy, and Phex(Ska1). Here we report analysis of two new spontaneous mutation in the mouse Phex gene, Phex(Hyp-2J) and Phex(Hyp-Duk). Phex(Hyp-2J) and Phex(Hyp-Duk) involve intragenic deletions of at least 7.3 kb containing exon 15, and 30 kb containing exons 13 and 14, respectively. Both mutations cause similar phenotypes in males, including shortened hind legs and tail, a shortened square trunk, hypophosphatemia, hypocalcemia, and rachitic bone disease. In addition, mice carrying the Phex(Hyp-Duk) mutation exhibit background-dependent variable expression of deafness, circling behavior, and cranial dysmorphology, demonstrating the influence of modifying genes on Phex-related phenotypes. Cochlear cross-sections from Phex(Hyp-2J)/Y and Phex(Hyp-Duk)/Y males reveal a thickening of the temporal bones surrounding the cochlea with the presence of a precipitate in the scala tympani. Evidence of the degeneration of the organ of Corti and spiral ganglion also are present in the hearing-impaired Phex(Hyp-Duk)/Y mice, but not in the normal-hearing Phex(Hyp-2J)/Y mice. Analysis of the phenotypes noted in Phex(Hyp-Duk)/Y and Phex(Hyp-2J)/Y males, together with those noted in Phex(Ska1)/Y and Phex(Hyp)/Y males, now allow XLH-related phenotypes to be separated from non-XLH-related phenotypes, such as those noted in Gy/Y males. Also, identification of the genetic modifiers of hearing and craniofacial dysmorphology in Phex(Hyp-Duk)/Y mice could provide insight into the phenotypic variation of XLH in humans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15029877      PMCID: PMC2859190          DOI: 10.1007/s00335-003-2310-z

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  26 in total

1.  An ethyl-nitrosourea-induced point mutation in phex causes exon skipping, x-linked hypophosphatemia, and rickets.

Authors:  Marina R Carpinelli; Ian P Wicks; Natalie A Sims; Kristy O'Donnell; Katherine Hanzinikolas; Rachel Burt; Simon J Foote; Melanie Bahlo; Warren S Alexander; Douglas J Hilton
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

2.  The Gy mutation: another cause of X-linked hypophosphatemia in mouse.

Authors:  M F Lyon; C R Scriver; L R Baker; H S Tenenhouse; J Kronick; S Mandla
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

3.  Electrocochleographic changes in the hearing loss associated with X-linked hypophosphataemic osteomalacia.

Authors:  S O'Malley; R T Ramsden; A Latif; R Kane; M Davies
Journal:  Acta Otolaryngol       Date:  1985 Jul-Aug       Impact factor: 1.494

4.  The petrous temporal bone and deafness in X-linked hypophosphataemic osteomalacia.

Authors:  S P O'Malley; J E Adams; M Davies; R T Ramsden
Journal:  Clin Radiol       Date:  1988-09       Impact factor: 2.350

5.  Impaired hearing in X-linked hypophosphataemic (vitamin-D-resistant) osteomalacia.

Authors:  M Davies; R Kane; J Valentine
Journal:  Ann Intern Med       Date:  1984-02       Impact factor: 25.391

6.  Patterns of matrix vesicle calcification in osteomalacia of Gyro mice.

Authors:  J Sela; I Bab; M S Deol
Journal:  Metab Bone Dis Relat Res       Date:  1982

7.  Audiometric evidence for two forms of X-linked hypophosphatemia in humans, apparent counterparts of Hyp and Gy mutations in mouse.

Authors:  A Boneh; T M Reade; C R Scriver; E Rishikof
Journal:  Am J Med Genet       Date:  1987-08

8.  Craniometric measurements of craniofacial malformations in the X-linked hypophosphatemic (Hyp) mouse on two different genetic backgrounds: C57BL/6J and B6C3H.

Authors:  C D Gonzalez; R A Meyer; R J Iorio
Journal:  Teratology       Date:  1992-12

9.  The X chromosome deletion in HYP mice extends into the intergenic region but does not include the SAT gene downstream from Phex.

Authors:  Y Sabbagh; C Gauthier; H S Tenenhouse
Journal:  Cytogenet Genome Res       Date:  2002       Impact factor: 1.636

10.  Craniofacial abnormalities in mice with X-linked hypophosphatemic genes (Hyp or Gy).

Authors:  N S Shetty; R A Meyer
Journal:  Teratology       Date:  1991-10
View more
  29 in total

Review 1.  The expanding family of hypophosphatemic syndromes.

Authors:  Thomas O Carpenter
Journal:  J Bone Miner Metab       Date:  2011-12-14       Impact factor: 2.626

2.  Discovery Genetics - The History and Future of Spontaneous Mutation Research.

Authors:  Muriel T Davisson; David E Bergstrom; Laura G Reinholdt; Leah Rae Donahue
Journal:  Curr Protoc Mouse Biol       Date:  2012-06-01

3.  A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells.

Authors:  Shoji Ichikawa; Anthony M Austin; Amie K Gray; Michael J Econs
Journal:  J Bone Miner Res       Date:  2012-02       Impact factor: 6.741

4.  Treatment of ear and bone disease in the Phex mouse mutant with dietary supplementation.

Authors:  Cameron C Wick; Sharon J Lin; Heping Yu; Cliff A Megerian; Qing Yin Zheng
Journal:  Am J Otolaryngol       Date:  2016-09-28       Impact factor: 1.808

5.  A mouse model validates the utility of electrocochleography in verifying endolymphatic hydrops.

Authors:  Sami J Melki; Yiping Li; Maroun T Semaan; Qing Yin Zheng; Cliff A Megerian; Kumar N Alagramam
Journal:  J Assoc Res Otolaryngol       Date:  2014-02-08

Review 6.  Hypophosphatemic rickets: lessons from disrupted FGF23 control of phosphorus homeostasis.

Authors:  Bracha K Goldsweig; Thomas O Carpenter
Journal:  Curr Osteoporos Rep       Date:  2015-04       Impact factor: 5.096

7.  Neither absence nor excess of FGF23 disturbs murine fetal-placental phosphorus homeostasis or prenatal skeletal development and mineralization.

Authors:  Yue Ma; Manoharee Samaraweera; Sandra Cooke-Hubley; Beth J Kirby; Andrew C Karaplis; Beate Lanske; Christopher S Kovacs
Journal:  Endocrinology       Date:  2014-03-06       Impact factor: 4.736

8.  Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.

Authors:  Despina Sitara; Mohammed S Razzaque; Martina Hesse; Subbiah Yoganathan; Takashi Taguchi; Reinhold G Erben; Harald Jüppner; Beate Lanske
Journal:  Matrix Biol       Date:  2004-11       Impact factor: 11.583

9.  A mouse model with postnatal endolymphatic hydrops and hearing loss.

Authors:  Cliff A Megerian; Maroun T Semaan; Saba Aftab; Lauren B Kisley; Qing Yin Zheng; Karen S Pawlowski; Charles G Wright; Kumar N Alagramam
Journal:  Hear Res       Date:  2008-01-15       Impact factor: 3.208

10.  Dosage effect of a Phex mutation in a murine model of X-linked hypophosphatemia.

Authors:  Shoji Ichikawa; Amie K Gray; Emmanuel Bikorimana; Michael J Econs
Journal:  Calcif Tissue Int       Date:  2013-05-23       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.